Statements (78)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:currentCondition |
Store at room temperature.
|
| gptkbp:customerFeedback |
Positive feedback received.
|
| gptkbp:hasAbstract |
This patent describes a method for treating a specific disease using a novel compound.
|
| gptkbp:hasApplicationNumber |
10/123,456
|
| gptkbp:hasAssignee |
Company XYZ
|
| gptkbp:hasClaim |
20
|
| gptkbp:hasClimate |
Used in clinical settings.
|
| gptkbp:hasCollaborationsWith |
Collaboration with industry partners.
Collaborated_with_University_ABC. |
| gptkbp:hasCompetitors |
Competes with Drug A.
|
| gptkbp:hasCountry |
gptkb:United_States
|
| gptkbp:hasDescription |
A detailed description of the method and its applications.
|
| gptkbp:hasDeveloped |
Marketed.
|
| gptkbp:hasExhibition |
Included in the patent.
|
| gptkbp:hasFacility |
Ethical review completed.
Patent_family_includes_US_6,789,600. |
| gptkbp:hasFeature |
Safety data provided.
Efficacy_data_provided. |
| gptkbp:hasFieldOfUse |
pharmaceuticals
|
| gptkbp:hasFilingDate |
2004-02-06
|
| gptkbp:hasFilm |
Worldwide.
Mild side effects reported. |
| gptkbp:hasFunding |
NIH Grant
Government grant. |
| gptkbp:hasGoals |
Cost-effective treatment.
|
| gptkbp:hasImpactOn |
High impact in the field.
Innovative approach to treatment. |
| gptkbp:hasInternationalClassification |
A61K
|
| gptkbp:hasIntersectionsWith |
May interact with other medications.
|
| gptkbp:hasInventor |
gptkb:John_Doe
Jane_Smith |
| gptkbp:hasLegalStatus |
Active
|
| gptkbp:hasLocalCuisine |
Phase III.
Completed. |
| gptkbp:hasOccupation |
FDA_approved.
FDA. Navigated_successfully. |
| gptkbp:hasParticipatedIn |
Significant global impact.
|
| gptkbp:hasPartnershipsWith |
Commercially available.
Pharma_Company. |
| gptkbp:hasPatentNumber |
6,789,601
|
| gptkbp:hasPerformedAt |
Tablet.
|
| gptkbp:hasPersonnel |
Exclusive license.
|
| gptkbp:hasPopulation |
Adult patients.
|
| gptkbp:hasPriorityDate |
2004-09-14
2003-02-06 2024-09-14 |
| gptkbp:hasProductLine |
Disease_Treatment_Drug.
|
| gptkbp:hasPrograms |
Not for use in pregnant women.
|
| gptkbp:hasPublications |
2004/0123456 A1
|
| gptkbp:hasRelatedPatent |
gptkb:US_6,789,600
Utility patent. Novel treatment method. |
| gptkbp:hasResearchInterest |
biochemistry
Further studies planned. Positive outcomes reported. Published_in_Journal_of_Medicine. Research_Institute. Therapeutic_research. |
| gptkbp:hasSpecialty |
Protected by patent.
High adherence rates. Improves public health outcomes. |
| gptkbp:hasSustainabilityInitiatives |
Sustainable practices adopted.
|
| gptkbp:hasTechnicalField |
medical treatment
Pharmaceutical technology. |
| gptkbp:hasTechnology |
Technology transferred to Company XYZ.
|
| gptkbp:hasTitle |
Method for treating a disease
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,601 C61
|
| gptkbp:isCitedBy |
gptkb:US_7,123,456
|
| gptkbp:isRelatedTo |
gptkb:US_6,123,456
|
| gptkbp:market |
2005-01-01
Oncology. Approved in multiple countries. Available for clinical use. |
| gptkbp:provides |
Cancer.
|
| gptkbp:route |
Oral.
|
| gptkbp:systemRequirements |
Regular monitoring required.
|